Chemical Name:5-(3-Bromophenyl)-7-[6-(4-morpholinyl)-3-pyrido[2,3-d]b
yrimidin-4-amine dihydrochloride
Biological Activity:
Potent non-nucleoside adenosine kinase inhibitor
(IC50=
1.7 nM), selective over other sites of adenosine interaction (A1, A2A
and A3 receptors, adenosine transporter and adenosine deaminase).
Displays oral activity in animal models of pain and inflammation.
Jarviset al (2000) ABT-702
(4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2, 3-d]pyrimidine),
a novel orally effective adenosine kinase inhibitor with analgesic and
anti-inflammatory properties: I. In vitro characterization and acute
antinociceptive effects in the mouse. J.Pharmacol.Exp.Ther. 295
1156. Kowaluk et
al (2000) ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-
3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase
inhibitor with analgesic and anti-inflammatory properties. II. In vivo
characterization in the rat. J.Pharmacol.Exp.Ther. 295 1165. Lee
et al (2001) Discovery of
4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin-3-yl)pyrido[2,3-d]pyrimidine,
an orally active, non-nucleoside adenosine kinase inhibitor. J.Med.Chem. 44
2133.